Outpatient visits down 60% because of COVID-19, study finds

From mid-March through mid-April, outpatient visits have declined nearly 60 percent due to COVID-19, according to research from Cambridge, Mass.-based Harvard University and healthcare technology company Phreesia. 

Advertisement

The decline is largely due to the cancellation and deferment of elective procedures and preventive visits. For their analysis, researchers from Harvard and Phreesia analyzed visit volume data from Phreesia’s more than 50,000 provider clients. 

Researchers found the New England and mid-Atlantic states saw the largest declines in the number of outpatient visits. As the number of in-person visits dropped, researchers saw the number of telehealth visits increase. However, the increase only partially offset the drop in in-person visits. 

To view the full report, click here.

More articles on patient flow:
Sparrow Hospital recommends COVID-19 patients take Uber home
Houston hospitals to resume some elective care
Massachusetts revises guidelines for crisis care amid unconscious bias concerns

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

From fragmentation to operational flow: Solving the healthcare workforce puzzle

Tuesday, August 11
1:00 PM - 2:00 PM CDT

Presenters: Dr. Pat Hunt, QGendaAndrea Daugherty, MHA, CISSP, CHCIO, CDH-E, Arrowhead Regional Medical CenterElizabeth Lindsay-Wood, MBA, CHCIO, CDH-E, Moffitt Cancer CenterDeb Muro, El Camino HealthJohn Tejeda, D.H.A., MLS, MPAS, DFAAPA, LSSBB, FACHE, Vascular and Neuroscience Institute

Advertisement

Next Up in Care Coordination

Advertisement

Comments are closed.